{"api":"v1","generated_at":"2026-10-02T14:56:41.188Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-capra-4a717f","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-capra-4a717f/at/2026-10-02T12-31Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-02T12:31:46.748Z","snapshot_stamp":"2026-10-02T12-31Z","endpoint":{"slug":"api-magentlab-com-api-calc-capra-4a717f","canonical_url":"https://api.magentlab.com/api/calc/capra","resource":"https://api.magentlab.com/api/calc/capra","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Cooperberg 2005 UCSF CAPRA preoperative score (Table 1). Caller-assigned PSA (>=2.1-6 0, >6-10 1, >10-20 2, >20-30 3, >30 4), Gleason 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3, clinical T t1/t2 0 or t3a 1, percent positive biopsies <34 0 or >=34 1, age <50 0 or >=50 1. Score 0-10. Table 4 bands 0_1, 2, 3, 4, 5, 6, ge_7 with 5-year RFS 85/81/66/59/60/34/8. Not Kattan. Not D'Amico. Not CAPRA-S. magent does not assay PSA or read biopsies. Not a diagnosis. Not a medical device.","service_name":"magent","declared_category":null,"declared_tags":["capra","prostate","cooperberg","prognosis","calculator"],"route_template":null,"registry_updated":"2026-09-28T13:54:53.588Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc capra","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-02T12:31:46.748Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-02T12:31:46.748Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T13:54:53.464Z"},"validation":{"latest":{"observed_at":"2026-10-02T14:26:11.435Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-02"},"uptime":[{"days":7,"observed":6,"passed":6,"ratio":1},{"days":30,"observed":6,"passed":6,"ratio":1},{"days":90,"observed":6,"passed":6,"ratio":1}],"history_90d":[{"observed_at":"2026-10-02T14:26:11.435Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T07:24:28.416Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T06:42:04.284Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:01:23.190Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:55:31.502Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:41:33.634Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["capra","prostate","cooperberg","prognosis","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/capra","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T13:54:53.464Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/capra","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age":62,"t_stage":"t1","psa_ng_ml":5,"gleason_primary":3,"gleason_secondary":3,"percent_positive_biopsies":20},{"age":62,"t_stage":"t1","psa_ng_ml":5,"gleason_primary":3,"gleason_secondary":3,"percent_positive_biopsies":20}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/capra","count":2,"items":[{"band":"0_1","score":1,"formula":"capra","t_stage":"t1","citation":{"id":"cooperberg-2005","doi":"10.1097/01.ju.0000158155.33890.e7","pmid":"15879786","title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","source":"J Urol. 2005;173(6):1938-1942","authors":"Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR"},"age_years":62,"max_score":10,"psa_ng_ml":5,"components":[{"value":5,"factor":"psa_ng_ml","points":0,"present":true},{"value":"3+3","factor":"gleason","points":0,"present":true},{"value":"t1","factor":"t_stage","points":0,"present":true},{"value":20,"factor":"percent_positive_biopsies","points":0,"present":true},{"value":62,"factor":"age","points":1,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","rfs_5y_percent":85,"gleason_primary":3,"gleason_secondary":3,"formula_expression":"CAPRA (Cooperberg 2005 Table 1) = psa_ng_ml (>=2.1 and <=6.0 0, >6.0 and <=10.0 1, >10.0 and <=20.0 2, >20.0 and <=30.0 3, >30 4; PSA <2.1 excluded) + gleason (primary/secondary 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3) + t_stage (t1 or t2 0, t3a 1) + percent_positive_biopsies (<34 0, >=34 1) + age (<50 0, >=50 1); score 0-10; Table 4 Kaplan-Meier bands 0_1 / 2 / 3 / 4 / 5 / 6 / ge_7 with 5-year RFS 85 / 81 / 66 / 59 / 60 / 34 / 8. Not Kattan nomogram. Not D'Amico groups. Not CAPRA-S","percent_positive_biopsies":20},{"band":"0_1","score":1,"formula":"capra","t_stage":"t1","citation":{"id":"cooperberg-2005","doi":"10.1097/01.ju.0000158155.33890.e7","pmid":"15879786","title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","source":"J Urol. 2005;173(6):1938-1942","authors":"Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR"},"age_years":62,"max_score":10,"psa_ng_ml":5,"components":[{"value":5,"factor":"psa_ng_ml","points":0,"present":true},{"value":"3+3","factor":"gleason","points":0,"present":true},{"value":"t1","factor":"t_stage","points":0,"present":true},{"value":20,"factor":"percent_positive_biopsies","points":0,"present":true},{"value":62,"factor":"age","points":1,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","rfs_5y_percent":85,"gleason_primary":3,"gleason_secondary":3,"formula_expression":"CAPRA (Cooperberg 2005 Table 1) = psa_ng_ml (>=2.1 and <=6.0 0, >6.0 and <=10.0 1, >10.0 and <=20.0 2, >20.0 and <=30.0 3, >30 4; PSA <2.1 excluded) + gleason (primary/secondary 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3) + t_stage (t1 or t2 0, t3a 1) + percent_positive_biopsies (<34 0, >=34 1) + age (<50 0, >=50 1); score 0-10; Table 4 Kaplan-Meier bands 0_1 / 2 / 3 / 4 / 5 / 6 / ge_7 with 5-year RFS 85 / 81 / 66 / 59 / 60 / 34 / 8. Not Kattan nomogram. Not D'Amico groups. Not CAPRA-S","percent_positive_biopsies":20}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age","psa_ng_ml","gleason_primary","gleason_secondary","t_stage","percent_positive_biopsies"],"properties":{"age":{"type":"integer","description":"Age in years (18-120, Params.age). Cooperberg 2005 Table 1: <50 scores 0; >=50 scores 1."},"t_stage":{"enum":["t1","t2","t3a"],"type":"string","description":"Clinical T as assigned by the caller (Cooperberg 2005 Table 1). t1 or t2 scores 0; t3a scores 1. Other stages are invalid. Not CAPRA-S pathologic T. magent does not assign TNM."},"psa_ng_ml":{"type":"number","description":"Preoperative PSA in ng/mL as assigned by the caller (2.1-500). Cooperberg 2005 Table 1: >=2.1 and <=6.0 scores 0; >6.0 and <=10.0 scores 1; >10.0 and <=20.0 scores 2; >20.0 and <=30.0 scores 3; >30 scores 4. PSA <2.1 is invalid (paper excluded PSA <2). magent does not assay PSA."},"gleason_primary":{"type":"integer","description":"Primary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_secondary: 1-3/1-3 scores 0; 1-3/4-5 scores 1; primary 4-5 scores 3. magent does not read biopsies."},"gleason_secondary":{"type":"integer","description":"Secondary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_primary as above. magent does not read biopsies."},"percent_positive_biopsies":{"type":"number","description":"Percent of biopsy cores positive (0-100) as assigned by the caller (Cooperberg 2005 Table 1). <34 scores 0; >=34 scores 1. magent does not read biopsies."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Cooperberg 2005 UCSF CAPRA preoperative score (Table 1). Caller-assigned PSA (>=2.1-6 0, >6-10 1, >10-20 2, >20-30 3, >30 4), Gleason 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3, clinical T t1/t2 0 or t3a 1, percent positive biopsies <34 0 or >=34 1, age <50 0 or >=50 1. Score 0-10. Table 4 bands 0_1, 2, 3, 4, 5, 6, ge_7 with 5-year RFS 85/81/66/59/60/34/8. Not Kattan. Not D'Amico. Not CAPRA-S. magent does not assay PSA or read biopsies. Not a diagnosis. Not a medical device.","lastUpdated":"2026-09-28T13:54:53.588Z","serviceName":"magent","x402Version":2}]}}